Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Pfützner

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Journal of Diabetes Science and Technology|January 10, 2012
Comment on "Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long acting versus short-acting insulins?"Andreas Pfützner
Endocrine Development|January 30, 2016
Diabetes TechnologyAndreas Pfützner
Journal of Diabetes Science and Technology|February 27, 2013
Variability of blood glucose meters for patient self-testing: analysis of the article by Brazg and coauthorsAndreas Pfützner
Journal of Diabetes Science and Technology|March 7, 2017
Patients' Preferences for Insulin Injection DevicesAndreas Pfützner
Journal of Diabetes Science and Technology|December 2, 2015
Advances in Patient Self-Monitoring of Blood GlucoseAndreas Pfützner
Expert Review of Medical Devices|March 21, 2009
FlexPen for the delivery of insulin: accuracy, injection force and patient preferenceAndreas Pfützner
Journal of Diabetes Science and Technology|November 28, 2014
A new metabolite panel test for identification of patients with impaired glucose tolerance? Analysis of the article by Cobb et alAndreas Pfützner
Diabetes Care|March 5, 2002
Response to Jungheim and KoschinskyAndreas Pfützner, Thomas Forst
Diabetes Technology & Therapeutics|February 14, 2006
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitusAndreas Pfützner, Thomas Forst
Expert Review of Endocrinology & Metabolism|February 9, 2019
Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitusThomas Forst, Andreas Pfützner
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Journal of Diabetes Science and Technology|January 10, 2012
Comment on "Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long acting versus short-acting insulins?"Andreas Pfützner
Endocrine Development|January 30, 2016
Diabetes TechnologyAndreas Pfützner
Journal of Diabetes Science and Technology|February 27, 2013
Variability of blood glucose meters for patient self-testing: analysis of the article by Brazg and coauthorsAndreas Pfützner
Journal of Diabetes Science and Technology|March 7, 2017
Patients' Preferences for Insulin Injection DevicesAndreas Pfützner
Journal of Diabetes Science and Technology|December 2, 2015
Advances in Patient Self-Monitoring of Blood GlucoseAndreas Pfützner
Expert Review of Medical Devices|March 21, 2009
FlexPen for the delivery of insulin: accuracy, injection force and patient preferenceAndreas Pfützner
Journal of Diabetes Science and Technology|November 28, 2014
A new metabolite panel test for identification of patients with impaired glucose tolerance? Analysis of the article by Cobb et alAndreas Pfützner
Diabetes Care|March 5, 2002
Response to Jungheim and KoschinskyAndreas Pfützner, Thomas Forst
Diabetes Technology & Therapeutics|February 14, 2006
High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitusAndreas Pfützner, Thomas Forst
Expert Review of Endocrinology & Metabolism|February 9, 2019
Clinical overview of linagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with Type 2 diabetes mellitusThomas Forst, Andreas Pfützner
Pageof 18